Log in
Sign Up. It's Free
Home
Ozempic®
Interactions
Drugs interactions for Ozempic®
Check individual interactions
0 Major drug
interactions
257 Moderate drug
interactions (including ingredients like Acarbose, Acebutolol, Acetylsalicylic acid)
37 Minor drug
interactions (including ingredients like Acetazolamide, Acetyl sulfisoxazole, Albuterol)
294 interactions for Ozempic®
Sort by
All drug interactions
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Ozempic®.
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Semaglutide.
Acebutolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Acebutolol.
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Semaglutide.
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Semaglutide.
Alogliptin
The risk or severity of hypoglycemia can be increased when Alogliptin is combined with Semaglutide.
Amcinonide
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Semaglutide.
Aminosalicylic acid
Aminosalicylic acid may increase the hypoglycemic activities of Semaglutide.
Amiodarone
The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Semaglutide.
Amitriptyline
Amitriptyline may decrease the hypoglycemic activities of Semaglutide.
Amlodipine
The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Semaglutide.
Amoxapine
Amoxapine may decrease the hypoglycemic activities of Semaglutide.
Aripiprazole
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Aripiprazole.
Arsenic trioxide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Asenapine.
Atazanavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Atazanavir.
Atenolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Atenolol.
Baclofen
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Baclofen.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Semaglutide.
Beclomethasone dipropionate
The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Semaglutide.
Benazepril
The risk or severity of hypoglycemia can be increased when Benazepril is combined with Semaglutide.
Bendroflumethiazide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Bendroflumethiazide.
Betamethasone
The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Semaglutide.
Betaxolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Betaxolol.
Bexagliflozin
Bexagliflozin may increase the hypoglycemic activities of Semaglutide.
Bismuth subsalicylate
Bismuth subsalicylate may increase the hypoglycemic activities of Semaglutide.
Bisoprolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Bisoprolol.
Brexpiprazole
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Brexpiprazole.
Bromocriptine
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Semaglutide.
Budesonide
The risk or severity of hyperglycemia can be increased when Budesonide is combined with Semaglutide.
Bumetanide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Bumetanide.
Canagliflozin
Canagliflozin may increase the hypoglycemic activities of Semaglutide.
Carvedilol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Carvedilol.
Ceritinib
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Ceritinib.
Chlorothiazide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Chlorothiazide.
Chlorpromazine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Chlorpromazine.
Chlorthalidone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Chlorthalidone.
Choline salicylate
Choline salicylate may increase the hypoglycemic activities of Semaglutide.
Ciclesonide
The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Semaglutide.
Ciprofloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Ciprofloxacin.
Citalopram
The risk or severity of hypoglycemia can be increased when Citalopram is combined with Semaglutide.
Clevidipine
The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Semaglutide.
Clobetasol propionate
The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Semaglutide.
Clocortolone
The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Semaglutide.
Clomipramine
Clomipramine may decrease the hypoglycemic activities of Semaglutide.
Clozapine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Clozapine.
Conjugated estrogens
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Conjugated estrogens.
Corticotropin
The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Semaglutide.
Cortisone acetate
The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Semaglutide.
Dabrafenib
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Dabrafenib.
Danazol
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Danazol.
Dapagliflozin
Dapagliflozin may increase the hypoglycemic activities of Semaglutide.
Darunavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Darunavir.
Deflazacort
The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Semaglutide.
Delafloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Delafloxacin.
Desipramine
Desipramine may decrease the hypoglycemic activities of Semaglutide.
Desogestrel
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Desogestrel.
Desonide
The risk or severity of hyperglycemia can be increased when Desonide is combined with Semaglutide.
Desoximetasone
The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Semaglutide.
Desvenlafaxine
The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Semaglutide.
Dexamethasone
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Semaglutide.
Dexamethasone acetate
The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Semaglutide.
Diazoxide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Diazoxide.
Dienogest
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Dienogest.
Diflorasone
The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Semaglutide.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Semaglutide.
Difluprednate
The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Semaglutide.
Diltiazem
The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Semaglutide.
Disopyramide
The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Semaglutide.
Doxepin
Doxepin may decrease the hypoglycemic activities of Semaglutide.
Drospirenone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Drospirenone.
Dulaglutide
The risk or severity of hypoglycemia can be increased when Dulaglutide is combined with Semaglutide.
Duloxetine
The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Semaglutide.
Empagliflozin
Empagliflozin may increase the hypoglycemic activities of Semaglutide.
Epinephrine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Epinephrine.
Ertugliflozin
Ertugliflozin may increase the hypoglycemic activities of Semaglutide.
Escitalopram
The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Semaglutide.
Estetrol
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Estetrol.
Estradiol
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Estradiol.
Estrone sulfate
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Estrone sulfate.
Etacrynic acid
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Etacrynic acid.
Ethinylestradiol
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Ethinylestradiol.
Ethosuximide
The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Semaglutide.
Ethynodiol diacetate
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Ethynodiol diacetate.
Etonogestrel
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Etonogestrel.
Everolimus
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Everolimus.
Exenatide
The risk or severity of hypoglycemia can be increased when Exenatide is combined with Semaglutide.
Felodipine
The risk or severity of hypoglycemia can be increased when Felodipine is combined with Semaglutide.
Fluconazole
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Fluconazole.
Fludrocortisone
The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Semaglutide.
Flunisolide
The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Semaglutide.
Fluocinolone acetonide
The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Semaglutide.
Fluocinonide
The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Semaglutide.
Fluorometholone
The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Semaglutide.
Fluoxetine
The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Semaglutide.
Flurandrenolide
The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Semaglutide.
Fluticasone furoate
The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Semaglutide.
Fluticasone propionate
The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Semaglutide.
Fluvoxamine
The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Semaglutide.
Fosamprenavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Fosamprenavir.
Furosemide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Furosemide.
Gatifloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Gatifloxacin.
Gemifloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Gemifloxacin.
Glimepiride
Semaglutide may increase the hypoglycemic activities of Glimepiride.
Glipizide
Semaglutide may increase the hypoglycemic activities of Glipizide.
Glyburide
Semaglutide may increase the hypoglycemic activities of Glyburide.
Goserelin
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Goserelin.
Halcinonide
The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Semaglutide.
Haloperidol
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Haloperidol.
Histrelin
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Semaglutide.
Hydrocortisone acetate
The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Semaglutide.
Hydrocortisone butyrate
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Semaglutide.
Hydrocortisone probutate
The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Semaglutide.
Hydrocortisone succinate
The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Semaglutide.
Hydrocortisone valerate
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Semaglutide.
Hydroflumethiazide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Hydroflumethiazide.
Hydroxychloroquine
The therapeutic efficacy of Semaglutide can be increased when used in combination with Hydroxychloroquine.
Hydroxyprogesterone caproate
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Iloperidone.
Imipramine
Imipramine may decrease the hypoglycemic activities of Semaglutide.
Indapamide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Indapamide.
Indinavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Indinavir.
Indomethacin
The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Semaglutide.
Insulin aspart
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin aspart.
Insulin degludec
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin degludec.
Insulin detemir
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin detemir.
Insulin glargine
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin glargine.
Insulin glulisine
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin glulisine.
Insulin human
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin human.
Insulin lispro
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin lispro.
Isoniazid
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Isoniazid.
Isradipine
The risk or severity of hypoglycemia can be increased when Isradipine is combined with Semaglutide.
Labetalol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Labetalol.
Lanreotide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Lanreotide.
Leuprolide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Leuprolide.
Levamlodipine
The risk or severity of hypoglycemia can be increased when Levamlodipine is combined with Semaglutide.
Levofloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Levofloxacin.
Levomilnacipran
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Semaglutide.
Levonorgestrel
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Levonorgestrel.
Levothyroxine
The serum concentration of Levothyroxine can be increased when it is combined with Semaglutide.
Linagliptin
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Semaglutide.
Liothyronine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Liothyronine.
Lipoic acid
The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Semaglutide.
Liraglutide
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Semaglutide.
Lixisenatide
The risk or severity of hypoglycemia can be increased when Lixisenatide is combined with Semaglutide.
Lomefloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Lomefloxacin.
Lonapegsomatropin
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Lonapegsomatropin.
Lopinavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Lopinavir.
Lurasidone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Lurasidone.
Magnesium sulfate
The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Semaglutide.
Mecasermin
The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Semaglutide.
Medroxyprogesterone acetate
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Medroxyprogesterone acetate.
Medrysone
The risk or severity of hyperglycemia can be increased when Medrysone is combined with Semaglutide.
Megestrol acetate
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Megestrol acetate.
Mesalazine
Mesalazine may increase the hypoglycemic activities of Semaglutide.
Metformin
The risk or severity of hypoglycemia can be increased when Metformin is combined with Semaglutide.
Methsuximide
The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Semaglutide.
Methyl salicylate
Methyl salicylate may increase the hypoglycemic activities of Semaglutide.
Methylprednisolone
The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Semaglutide.
Methylprednisolone hemisuccinate
The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Semaglutide.
Metolazone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Metolazone.
Metoprolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Metoprolol.
Mifepristone
The risk or severity of hypoglycemia can be increased when Mifepristone is combined with Semaglutide.
Miglitol
The risk or severity of hypoglycemia can be increased when Miglitol is combined with Semaglutide.
Milnacipran
The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Semaglutide.
Mometasone furoate
The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Semaglutide.
Moxifloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Moxifloxacin.
Nadolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Nadolol.
Nateglinide
The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Semaglutide.
Nebivolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Nebivolol.
Nefazodone
The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Semaglutide.
Nelfinavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Nelfinavir.
Niacin
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Niacin.
Nicardipine
The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Semaglutide.
Nifedipine
The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Semaglutide.
Nilotinib
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Nilotinib.
Nimodipine
The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Semaglutide.
Nisoldipine
The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Semaglutide.
Norethisterone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Norethisterone.
Norgestimate
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Norgestimate.
Nortriptyline
Nortriptyline may decrease the hypoglycemic activities of Semaglutide.
Octreotide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Octreotide.
Ofloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Ofloxacin.
Olanzapine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Semaglutide.
Paliperidone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Paliperidone.
Paroxetine
The risk or severity of hypoglycemia can be increased when Paroxetine is combined with Semaglutide.
Pasireotide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Pasireotide.
Pegvisomant
The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Semaglutide.
Pentamidine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Pentamidine.
Phentermine
The therapeutic efficacy of Semaglutide can be increased when used in combination with Phentermine.
Phenytoin
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Phenytoin.
Pinaverium
The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Semaglutide.
Pindolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Pindolol.
Pioglitazone
The risk or severity of hypoglycemia can be increased when Pioglitazone is combined with Semaglutide.
Polythiazide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Polythiazide.
Pramlintide
The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Semaglutide.
Prednicarbate
The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Semaglutide.
Prednisolone
The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Semaglutide.
Prednisolone acetate
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Semaglutide.
Prednisolone phosphate
The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Semaglutide.
Prednisone
The risk or severity of hyperglycemia can be increased when Prednisone is combined with Semaglutide.
Pregabalin
The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Semaglutide.
Progesterone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Progesterone.
Propafenone
The therapeutic efficacy of Semaglutide can be increased when used in combination with Propafenone.
Propranolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Propranolol.
Protriptyline
Protriptyline may decrease the hypoglycemic activities of Semaglutide.
Pseudoephedrine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Pseudoephedrine.
Quetiapine
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Quetiapine.
Quinine
The risk or severity of hypoglycemia can be increased when Quinine is combined with Semaglutide.
Repaglinide
The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Semaglutide.
Risperidone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Ritonavir.
Rosiglitazone
The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Semaglutide.
Salicylic acid
Salicylic acid may increase the hypoglycemic activities of Semaglutide.
Saquinavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Saquinavir.
Saxagliptin
The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Semaglutide.
Sertraline
The risk or severity of hypoglycemia can be increased when Sertraline is combined with Semaglutide.
Sirolimus
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Sirolimus.
Sitagliptin
The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Semaglutide.
Somapacitan
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Somapacitan.
Somatotropin
Somatotropin may decrease the hypoglycemic activities of Semaglutide.
Somatrogon
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Somatrogon.
Sotagliflozin
The risk or severity of hypoglycemia can be increased when Sotagliflozin is combined with Semaglutide.
Sotalol
The risk or severity of hypoglycemia can be increased when Sotalol is combined with Semaglutide.
Sulfadiazine
The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Semaglutide.
Sulfamethoxazole
The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Semaglutide.
Sulfasalazine
Sulfasalazine may increase the hypoglycemic activities of Semaglutide.
Sunitinib
The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Semaglutide.
Tacrolimus
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Tacrolimus.
Temsirolimus
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Temsirolimus.
Teprotumumab
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Teprotumumab.
Thyroid, porcine
Thyroid, porcine may decrease the hypoglycemic activities of Semaglutide.
Thyrotropin alfa
Thyrotropin alfa may decrease the hypoglycemic activities of Semaglutide.
Timolol
The therapeutic efficacy of Semaglutide can be increased when used in combination with Timolol.
Tipranavir
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Tipranavir.
Tirzepatide
The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Tirzepatide.
Tixocortol
The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Semaglutide.
Tolazamide
Semaglutide may increase the hypoglycemic activities of Tolazamide.
Torasemide
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Torasemide.
Triamcinolone
The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Semaglutide.
Trimipramine
Trimipramine may decrease the hypoglycemic activities of Semaglutide.
Triptorelin
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Triptorelin.
Trolamine salicylate
Trolamine salicylate may increase the hypoglycemic activities of Semaglutide.
Trovafloxacin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Trovafloxacin.
Ubidecarenone
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Semaglutide.
Ulobetasol
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Semaglutide.
Vamorolone
The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Semaglutide.
Venlafaxine
The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Semaglutide.
Verapamil
The risk or severity of hypoglycemia can be increased when Verapamil is combined with Semaglutide.
Vorinostat
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Vorinostat.
Xylometazoline
The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Semaglutide.
Ziconotide
The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Semaglutide.
Ziprasidone
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Ziprasidone.
Zonisamide
The risk or severity of hypoglycemia can be increased when Zonisamide is combined with Semaglutide.
Acetazolamide
The therapeutic efficacy of Semaglutide can be increased when used in combination with Acetazolamide.
Acetyl sulfisoxazole
The therapeutic efficacy of Semaglutide can be increased when used in combination with Acetyl sulfisoxazole.
Albuterol
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Albuterol.
Bosentan
The therapeutic efficacy of Semaglutide can be increased when used in combination with Bosentan.
Celecoxib
The therapeutic efficacy of Semaglutide can be increased when used in combination with Celecoxib.
Diclofenamide
The therapeutic efficacy of Semaglutide can be increased when used in combination with Diclofenamide.
Fedratinib
The therapeutic efficacy of Semaglutide can be increased when used in combination with Fedratinib.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Semaglutide.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Semaglutide.
Linezolid
Linezolid may increase the hypoglycemic activities of Semaglutide.
Lithium carbonate
The therapeutic efficacy of Semaglutide can be decreased when used in combination with Lithium carbonate.
Methazolamide
The therapeutic efficacy of Semaglutide can be increased when used in combination with Methazolamide.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Semaglutide.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Semaglutide.
Mitapivat
The therapeutic efficacy of Semaglutide can be increased when used in combination with Mitapivat.
Nandrolone decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Semaglutide.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Semaglutide.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Semaglutide.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Semaglutide.
Probenecid
The therapeutic efficacy of Semaglutide can be increased when used in combination with Probenecid.
Procaine
Procaine may increase the hypoglycemic activities of Semaglutide.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Semaglutide.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Semaglutide.
Rosuvastatin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Rosuvastatin.
Safinamide
Safinamide may increase the hypoglycemic activities of Semaglutide.
Selegiline
Selegiline may increase the hypoglycemic activities of Semaglutide.
Sulfamethizole
The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfamethizole.
Sumatriptan
The therapeutic efficacy of Semaglutide can be increased when used in combination with Sumatriptan.
Tamsulosin
The therapeutic efficacy of Semaglutide can be increased when used in combination with Tamsulosin.
Testosterone
Testosterone may increase the hypoglycemic activities of Semaglutide.
Testosterone cypionate
Testosterone cypionate may increase the hypoglycemic activities of Semaglutide.
Testosterone enanthate
Testosterone enanthate may increase the hypoglycemic activities of Semaglutide.
Testosterone propionate
Testosterone propionate may increase the hypoglycemic activities of Semaglutide.
Testosterone undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Semaglutide.
Tranylcypromine
Tranylcypromine may increase the hypoglycemic activities of Semaglutide.
Valdecoxib
The therapeutic efficacy of Semaglutide can be increased when used in combination with Valdecoxib.
Vemurafenib
The therapeutic efficacy of Semaglutide can be increased when used in combination with Vemurafenib.
Otomatik - 13.107.246.60
CloudFlare DNS
Türk Telekom DNS
Google DNS
Open DNS
OSZAR »
